Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
November 07, 2007
Allergan, Inc v. Photomedex, Inc, et al
Case Number:
8:07-cv-01316
Court:
Nature of Suit:
Judge:
Firms
- Alston Hunt
- Ascension Law Group
- Conkle Kremer
- Dentons
- Dunlap Codding
- Finlayson Toffer
- Fish & Richardson
- Gallagher & Kennedy
- Gibson Dunn
- Graves & Shaw
- Hagens Berman
- Honigman LLP
- Jeffer Mangels
- Katten Muchin
- K&L Gates
- Knobbe Martens
- KXT Law
- Merchant & Gould
- Mintz Levin
- Morgan Lewis
- Perkins Coie
- Russ August & Kabat
- Sheppard Mullin
- Taft Stettinius
- Toberoff & Associates
- Towle Denison
- Venable LLP
- Warner Norcross
- Weiss & Moy
- Zuber Lawler
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 29, 2013
Allergan Drops Patent, Ad Claims Over Eyelash Drug Latisse
A California federal judge Thursday brought closer to an end Allergan Inc.'s long-running patent infringement and false advertising suit over its eyelash-enhancing drug Latisse after the company inked a deal that dropped competition and noninfringement claims by three rivals.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login